Download FREE Sample
Report Overview
A contract research organization (CRO) provides comprehensive clinical trial services for the pharmaceutical, biotechnology, and medical device sectors. CRO services majorly include clinical research services, early-phase development services, laboratory services, consulting services, among others. Some of the typical reasons why the pharmaceutical, biotechnology, and medical devices industries outsource to CROs include, better return on R&D investments, lack of internal capabilities (esp. small biopharma companies), increasing complexity in developing targeted therapeutic areas like immuno-oncology therapies, stringent regulatory requirements, to focus on core competencies, strategic choice, and time and cost-efficiency among others.
To learn more about this report, download the PDF brochure
Growing Investments from Governments, Private Companies, and Venture Capitalists to Drive Market Growth
In recent years, fundings and investments in CRISPR technology have been significant, showcasing the growing interest and support for this innovative field. In February 2024, CRISPR Therapeutics secured approximately USD 280 million through an agreement to sell its common shares to a select group of institutional investors. This investment aims to accelerate their gene-editing programs and expand their therapeutic pipeline. Another notable example is the Indian biotechnology start-up CrisprBits, which raised USD 250,000 in pre-seed funding from US-based VJ Group in February 2023. This funding is intended for developing CRISPR-based diagnostics to detect pathogens and antimicrobial resistance genes. Likewise, in July 2023, Pfizer Inc. made a USD 25 million equity investment in Caribou Biosciences, Inc. a leading clinical-stage CRISPR genome-editing biopharmaceutical company. These examples highlight the substantial financial support and confidence in the potential of CRISPR technology.
To learn more about this report, download the PDF brochure
Market trend towards full-service CROs/one-stop-shop model
The shift toward full-service CROs is driven by the complexities of modern drug development. Biopharma companies prefer CROs that offer end-to-end services, from pre-clinical research to commercialization, ensuring streamlined processes, cost efficiency, and reduced timelines. Full-service CROs provide scalable resources, specialized expertise, and global reach, enabling seamless international trials and regulatory compliance. Their ability to manage entire projects eliminates the need for multiple vendors, improving efficiency. With advanced technologies and therapeutic expertise, these CROs deliver high-quality outcomes, making them the preferred choice for navigating the evolving drug development landscape and accelerating market entry.
Competitive Landscape Analysis
The global contract research organization (CRO) services market is marked by the presence of established and emerging market players such as IQVIA, Labcorp, Syneos Health, Thermo Fisher Scientific, Parexel, ICON, Charles River, WUXI Apptec, Pharmacon Beijing, and SGS; among others. Some of the key strategies adopted by market players include new service launches, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Scope | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 2024 |
| Forecast Period | 2025 2030 |
| Growth Rate | 9% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Service Type, Therapy Area, End User |
| Regional Scope |
|
| Key Companies Mapped | IQVIA, Labcorp, Syneos Health, Thermo Fisher Scientific, Parexel, ICON, Charles River, WUXI Apptec, Pharmacon Beijing, and SGS among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Market Segmentation
This report by Medi-Tech Insights provides thesize of the global contract research organization (CRO) services market at theregional- and country-level from 2023 to 2030. The report further segments the market based on service type, therapy area, end user.
- Market Size & Forecast (2023-2030), By Service Type, USD Million
- Clinical Research Services
- By Phase
- Phase III
- Phase II
- Phase I
- Phase IV
- By Study Design
- Interventional
- Real World Evidence (RWE)
- Early-phase Development Services
- Chemistry, Manufacturing and Controls Services
- Preclinical Services
- Pharmacokinetics/ Pharmacodynamics Services
- Toxicology Testing Services
- Other Preclinical Services
- Discovery Studies
- Laboratory Services
- Analytical Testing Services
- Physical Charaerization Services
- Raw Material Testing Services
- Batch Release Testing Services
- Stability Testing Services
- Other Analytical Testing Services
- Bioanalytical Testing Services
- Analytical Testing Services
- Consulting Services
- Other Services
- By Phase
- Clinical Research Services
- Market Size & Forecast (2023-2030), By Therapy Area, USD Million
- Oncology
- Infectious Diseases
- CVS Disorders
- Neurology
- Vaccines
- Endocrinology
- Immunological Disorders
- Mental Health Disorders
- Dermatology
- Ophthalmology
- Others
- Market Size & Forecast (2023-2030), By End User, USD Million
- Pharmaceutical & Biotechnology Companies
- Medical Device Companies
- Other End Users
- Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
- North America
Key Strategic Questions Addressed
- What is the market size & forecast of the CRISPR technology market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the CRISPR technology market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
Need a More Tailored Analysis?
- Discuss the market sizing methodology and forecast assumptions with our healthcare analysts.
- Expand the scope with additional countries, market segments, technologies, or competitor profiling.
- Use the insights to support strategic planning, market entry, commercial due diligence, and long-term revenue growth initiatives.
